Octreotide and Tamoxifen in Combination Increase Survival Time of Patients With Pancreatic Cancer

Journal of the American Osteopathic Association, The - United States
doi 10.7556/jaoa.1995.95.2.87a
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Osteopathic Association

Related search

Table 4: Multivariate Analyses of Overall Survival in Patients With Pancreatic Cancer.

English

Effective Pain Therapy Can Improve Survival in the Patients With Pancreatic Cancer

Agri Dergisi
AnesthesiologyPain Medicine
2019English

Body Mass Index and Risk, Age of Onset, and Survival in Patients With Pancreatic Cancer

JAMA - Journal of the American Medical Association
Medicine
2009English

Cannabinoids in Pancreatic Cancer: Correlation With Survival and Pain

International Journal of Cancer
Cancer ResearchOncology
2008English

Mean Platelet Volume Predicts Survival in Pancreatic Cancer Patients With Synchronous Liver Metastases

Scientific Reports
Multidisciplinary
2018English

The Effect of Combined Treatment Methods on Survival and Toxicity in Patients With Pancreatic Cancer

Medicina
Medicine
2007English

Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer

Cancer Journal
Cancer ResearchOncology
2015English

Octreotide LAR Dosage and Survival Among Elderly Patients With Distant-Stage Neuroendocrine Tumors

Oncologist
Cancer ResearchMedicineOncology
2016English

CA19–9 Decrease and Survival According to Platelet Level in Patients With Advanced Pancreatic Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy